Novozymes A/S reports 1H results (Pink Limited Info:NVZMF)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 28 2024
0mins
Should l Buy ?
Source: SeekingAlpha
Financial Performance: Novozymes A/S reported a GAAP EPS of EUR 0.14 for the first half of the year, with sales reaching EUR 1,831.7 million, up from EUR 1,187.1 million in the previous year.
Sales Growth: The company achieved an organic pro forma sales growth of 7% and an 8% increase on an IFRS reported basis during the same period.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
